Latest Updates

News

Aug 17, 2022

Changing A Name: More Than An Academic Exercise

Aug 17, 2022

People living with NASH, patients and families, whose lives and livelihoods are at risk from a liver disease few outside of a small circle of academic and clinical experts had heard of a few years ago have very practical, urgent needs:

Disease education/awareness (for patients, providers, payers, policymakers)
Development and designation of simplified non-invasive testing and expanded screening (get beyond the biopsy)
FDA-approval of NASH drugs, devices, and diagnostics (find a treatment)
Clinical environments organized to provide coordinated integrated care to people at every stage of the NAFLD-NASH spectrum

Aug 17, 2022

Aug 12, 2022

Global Liver Institute Congratulates Dr. Monica Bertagnolli for Imminent Appointment as Director of the National Cancer Institute

Aug 12, 2022

As leaders in the liver cancers community, Global Liver Institute (GLI) proudly supports President Biden’s selection of Monica Bertagnolli, MD, to be appointed as the Director of the National Cancer Institute (NCI).

Aug 12, 2022

Jun 13, 2022

The Embassy of Italy Joins Global Liver Institute to commemorate International NASH Day

Jun 13, 2022

(Washington, DC - June 14, 2022) – The Embassy of Italy, in collaboration with Global Liver Institute (GLI), will host an event on June 14 entitled “From Progress in the Control of Viral Hepatitis to the Rising Epidemic of NASH” for the occasion of International NASH Day, a liver health awareness campaign led annually by GLI in June. The event will feature a scientific presentation highlighting the bilateral efforts to improve liver health in Italy and the United States, with a robust lineup of speakers.

Jun 13, 2022

More news and events

GLI in Action

Exciting meeting with Dr. Lynn Gerber and the rest of the Beatty Liver & Obesity Research Program team at Inova Fairfax Hospital. Many opportunities to collaborate on patient-centric research!

Advanced Advocacy Academy Class of 2019

GLI's A3 Advanced Advocacy Academy

Class of 2018 alumni, faculty, and staff

Expert Advocates

Donna Cryer, Adam Taliaferro, and Karen Hoyt at A3

Liver Transplantees Practice Advocacy

Kimberly Martinez, A3 2018 alum, and Donna Cryer, JD, GLI President & CEO

GLI Staff and Summer Interns at A3

Jonathan Faure, Carrie Gelula, Claire Ubersax, Jen DelGrande, Donna Cryer, Jeniece Montellano, and Richard Gelula

Advanced Advocates

Karen Hoyt, Paulette Hatfield, Bel Kambach, Brianne Farley, Leslie Stratta at GLI’s A3

A3 Connections

Advanced Advocates Steve Scheier, Darnella Allen, Donna Cryer, and Karen Hoyt

The Power of Advocacy

A3 Faculty member Adam Taliaferro with Alumni Anthony and Betsy Villiotti

Lessons in Storytelling & Media

Interviews such as this one, conducted with Steven West at A3, 2018, help our advocates share their stories and messages with the world

Research Advisory Board

Patient and caregiver members of the research advisory board for the palliative care in end-stage liver disease PCORI grant meet at Einstein in Philadelphia

Drs. Victor Navarro and Manisha Verma with GLI President & CEO, Donna Cryer at Einstein in Philadelphia for the research advisory board meeting

NASH Council Co-chairs

Anna Mae Diehl, MD, Duke University School of Medicine
Donna R. Cryer, JD, Global Liver Institute

NASH Council 2018 Panel: Key NASH Initiatives

Pascaline Clerc, PhD, NASH Education Program
Katherine Greene, MPH, Liver Forum
Donna Cryer, JD, Global Liver Institute
Elizabeth Clearfield, MHS, Center for Medical Technology Policy

NASH Council 2018: Activating and Integrating NASH Patients

Wayne Eskridge, Fatty Liver Foundation
Donna R. Cryer, JD, Global Liver Institute

European Liver Patients Association

GLI president and CEO, Donna Cryer with Marko Korenjak, ELPA, and Tara Farrell, World Hepatitis Alliance

GLI at AHIP 2018

GLI's President & CEO, Donna Cryer with Elisabeth Rosenthal, Editor-in Chief of Kaiser Health News, and Amy Tendrich, Founder/Editor-in-Chief of DiabetesMine

GLI Thanks its A3 Sponsors

GLI staff and board members thank the A3 sponsors: Amgen, Astellas, Bristol-Myers Squibb, Gilead, Lilly, PhRMA

GLI's Advanced Advocacy Academy

Class of 2017 alumni, faculty, and staff

Donna Cryer with A3 Faculty Members

Anna Farris, LUNGevity, Donna Cryer, JD, GLI, and Steven Grossman, JD, HPS Group

Donna Cryer, GLI, Ryan Clary, NVHR and Chris Taylor, NASTAD

2017 NASH Council Meeting

Marko Korenjak of the European Liver Patients Association, GLI President & CEO, Donna Cryer, and Wayne Eskridge of the Fatty Liver Foundation

GLI CEO & President, Donna Cryer, Luke Timmerman and Dr. William Hait before their BIO 2017 panel on A World without Disease: Can we get there?

Panel at BIO 2017: A World Without Disease: Can We Get There?
Mike Cobur, Research! America
Donna Cryer, JD, Global Liver Institute
William Hait, Janssen Research & Development, LLC
Mark McClellan, MD, PhD, Duke University
Luke Timmerman, Timmerman Report

Panel at BIO 2017: The Whole Picture: Consideration of Personalized Medicine in Value Assessment Frameworks
Mitch Higashi BMS
Donna Cryer, JD, Global Liver Institute
Jennifer Snow, Xcenda
Roger Longman, Real Endpoints